Dr. Reddy’s Laboratories secures key European endorsement for Rituximab biosimilar
In a significant development for the pharmaceutical industry, Dr. Reddy’s Laboratories Ltd. has received a positive opinion from the European Medicines Agency’s (EMA) Committee for ... Read More
UK MHRA approves first generic raltegravir medicines for HIV treatment
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for the first generic raltegravir medicines, designed to treat adult and pediatric HIV ... Read More
Mundipharma’s rezafungin cleared by MHRA for invasive candidiasis in Great Britain
In a significant advancement for antifungal therapy, Napp Pharmaceuticals Limited, a key player within the international network of Mundipharma independent associated companies, has announced the ... Read More